As of 2026-02-07, the Relative Valuation of Cue Biopharma Inc (CUE) is (6.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.31 USD, the upside of Cue Biopharma Inc based on Relative Valuation is -2294.4%.
The range of the Relative Valuation is (5.46) - (7.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 19.9x | 17.8x |
| Forward P/E multiples | 14.4x - 22.4x | 18.0x |
| Fair Price | (5.46) - (7.54) | (6.79) |
| Upside | -1865.3% - -2537.1% | -2294.4% |
| Date | P/E |
| 2026-02-04 | -0.82 |
| 2026-02-03 | -0.87 |
| 2026-02-02 | -0.90 |
| 2026-01-30 | -0.88 |
| 2026-01-29 | -0.95 |
| 2026-01-28 | -0.98 |
| 2026-01-27 | -1.03 |
| 2026-01-26 | -0.96 |
| 2026-01-23 | -1.00 |
| 2026-01-22 | -0.96 |
| 2026-01-21 | -0.99 |
| 2026-01-20 | -0.79 |
| 2026-01-16 | -0.80 |
| 2026-01-15 | -0.73 |
| 2026-01-14 | -0.90 |
| 2026-01-13 | -0.92 |
| 2026-01-12 | -0.91 |
| 2026-01-09 | -0.95 |
| 2026-01-08 | -1.04 |
| 2026-01-07 | -1.02 |
| 2026-01-06 | -0.97 |
| 2026-01-05 | -1.01 |
| 2026-01-02 | -0.89 |
| 2025-12-31 | -0.81 |
| 2025-12-30 | -0.80 |
| 2025-12-29 | -0.73 |
| 2025-12-26 | -0.86 |
| 2025-12-24 | -0.64 |
| 2025-12-23 | -0.64 |
| 2025-12-22 | -0.67 |
| 2025-12-19 | -0.71 |
| 2025-12-18 | -0.90 |
| 2025-12-17 | -1.06 |
| 2025-12-16 | -1.08 |
| 2025-12-15 | -1.22 |
| 2025-12-12 | -1.29 |
| 2025-12-11 | -1.30 |
| 2025-12-10 | -1.26 |
| 2025-12-09 | -1.30 |
| 2025-12-08 | -1.39 |
| 2025-12-05 | -1.45 |
| 2025-12-04 | -1.46 |
| 2025-12-03 | -1.48 |
| 2025-12-02 | -1.51 |
| 2025-12-01 | -1.57 |
| 2025-11-28 | -1.66 |
| 2025-11-26 | -1.65 |
| 2025-11-25 | -1.61 |
| 2025-11-24 | -1.56 |
| 2025-11-21 | -1.57 |